Amgen’s Latest Study: A New Contender in Lung Cancer Treatment?

1 month ago 28

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a pivotal study titled ‘A Randomized, Double-blind Study to Compar...

1. Homepage
2. Lung Cancer
3. Amgen’s Latest Study: A New Contender in Lung Cancer Treatment?